BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10837536)

  • 1. Inhibitors of glutathione S-transferases as therapeutic agents.
    Tew KD; Dutta S; Schultz M
    Adv Drug Deliv Rev; 1997 Jul; 26(2-3):91-104. PubMed ID: 10837536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate.
    Awasthi S; Srivastava SK; Ahmad F; Ahmad H; Ansari GA
    Biochim Biophys Acta; 1993 Jul; 1164(2):173-8. PubMed ID: 8329448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione-dependent biotransformation of the alkylating drug thiotepa and transport of its metabolite monoglutathionylthiotepa in human MCF-7 breast cancer cells.
    Cnubben NH; Rommens AJ; Oudshoorn MJ; Van Bladeren PJ
    Cancer Res; 1998 Oct; 58(20):4616-23. PubMed ID: 9788613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferases as emerging therapeutic targets.
    Gaté L; Tew KD
    Expert Opin Ther Targets; 2001 Aug; 5(4):477-489. PubMed ID: 12540261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of ligands interaction models for glutathione-S-transferases from Plasmodium falciparum, human and mouse using enzyme kinetics and molecular docking.
    Al-Qattan MN; Mordi MN; Mansor SM
    Comput Biol Chem; 2016 Oct; 64():237-249. PubMed ID: 27475235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of glutathione-S-transferases in zebrafish (Danio rerio).
    Glisic B; Mihaljevic I; Popovic M; Zaja R; Loncar J; Fent K; Kovacevic R; Smital T
    Aquat Toxicol; 2015 Jan; 158():50-62. PubMed ID: 25461745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method for screening the glutathione transferase inhibitors.
    Wang Z; Jin L; Wegrzyn G; Wegrzyn A
    BMC Biochem; 2009 Mar; 10():6. PubMed ID: 19291299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor.
    Prade L; Huber R; Manoharan TH; Fahl WE; Reuter W
    Structure; 1997 Oct; 5(10):1287-95. PubMed ID: 9351803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit aorta glutathione S-transferases and their role in bioactivation of trinitroglycerin.
    Singhal SS; Piper JT; Srivastava SK; Chaubey M; Bandorowicz-Pikula J; Awasthi S; Awasthi YC
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):378-86. PubMed ID: 8887455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione-associated enzymes in anticancer drug resistance.
    Tew KD
    Cancer Res; 1994 Aug; 54(16):4313-20. PubMed ID: 8044778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity.
    Parody JP; Alvarez Mde L; Quiroga A; Ronco MT; Francés D; Carnovale C; Carrillo MC
    Arch Toxicol; 2007 Aug; 81(8):565-73. PubMed ID: 17340122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-specific oligonucleotide probes for alpha, mu, pi, and microsomal rat glutathione S-transferases: analysis of liver transferase expression and its modulation by hepatic enzyme inducers and platinum anticancer drugs.
    Waxman DJ; Sundseth SS; Srivastava PK; Lapenson DP
    Cancer Res; 1992 Oct; 52(20):5797-802. PubMed ID: 1394205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
    Townsend AJ; Tu CP; Cowan KH
    Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling.
    Burg D; Riepsaame J; Pont C; Mulder G; van de Water B
    Biochem Pharmacol; 2006 Jan; 71(3):268-77. PubMed ID: 16337611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-cancer drug resistance and glutathione S-transferases].
    Sato K; Tsuchida S; Tamai K
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):592-8. PubMed ID: 2650631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of glutathione and associated enzymes in drug response.
    Shen H; Kauvar L; Tew KD
    Oncol Res; 1997; 9(6-7):295-302. PubMed ID: 9406235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.
    Hayes JD; Pulford DJ
    Crit Rev Biochem Mol Biol; 1995; 30(6):445-600. PubMed ID: 8770536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa.
    Srivastava SK; Singhal SS; Hu X; Awasthi YC; Zimniak P; Singh SV
    Arch Biochem Biophys; 1999 Jun; 366(1):89-94. PubMed ID: 10334868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Inhibition of Human Placental Glutathione S-Transferase by 3-Arylcoumarin Derivatives.
    Alparslan MM; Danış Ö
    Arch Pharm (Weinheim); 2015 Sep; 348(9):635-42. PubMed ID: 26205366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features.
    Ertan-Bolelli T; Musdal Y; Bolelli K; Yilmaz S; Aksoy Y; Yildiz I; Aki-Yalcin E; Yalcin I
    ChemMedChem; 2014 May; 9(5):984-92. PubMed ID: 24677708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.